Cytomaxes is a dietary supplements developed in St. Petersburg Institute of Bioregulation and Gerontology (Russia).
The active ingredient of Cytomaxes is a synthesized tripeptide analogs of endogenous peptides isolated from animal organs and tissues.
Each Cytomax product has its own indications for use and is intended to treat diseases of certain organs, e.g Cerluten is used to treat neurological disorders, while Chelohart is used to treat cardiac diseases.
Cytomaxes are considered dietary supplements, thus their efficacy is questionable and they are regulated as supplements, not as pharmaceutical drugs.